Panagene Inc
KOSDAQ:046210
Panagene Inc
Interest Income Expense
Panagene Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Panagene Inc
KOSDAQ:046210
|
Interest Income Expense
₩1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
Celltrion Inc
KRX:068270
|
Interest Income Expense
₩22.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
177%
|
CAGR 10-Years
1%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Interest Income Expense
₩19.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Interest Income Expense
₩14B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Interest Income Expense
₩12.4B
|
CAGR 3-Years
54%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Interest Income Expense
₩6.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
See Also
What is Panagene Inc's Interest Income Expense?
Interest Income Expense
1.5B
KRW
Based on the financial report for Dec 31, 2023, Panagene Inc's Interest Income Expense amounts to 1.5B KRW.
What is Panagene Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
42%
Over the last year, the Interest Income Expense growth was 188%.